Literature DB >> 20871707

Cost savings and luteinizing hormone-releasing hormone agonist.

Steven Tucker.   

Abstract

Year:  2006        PMID： 20871707      PMCID： PMC2794587          DOI： 10.1200/JOP.2006.2.3.103

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  3 in total

1.  Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry.

Authors:  Christina Wang; Don H Catlin; Laurence M Demers; Borislav Starcevic; Ronald S Swerdloff
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

2.  Individualized strategy for dosing luteinizing hormone-releasing hormone agonists for androgen-independent prostate cancer: identification of outcomes and costs.

Authors:  Jennifer A Wagmiller; Jennifer J Griggs; Andrew W Dick; Deepak M Sahasrabudhe
Journal:  J Oncol Pract       Date:  2006-03       Impact factor: 3.840

3.  Molecular determinants of resistance to antiandrogen therapy.

Authors:  Charlie D Chen; Derek S Welsbie; Chris Tran; Sung Hee Baek; Randy Chen; Robert Vessella; Michael G Rosenfeld; Charles L Sawyers
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.